Reading the Southern Med Review teaches me something about 'Everywhere Else' and in the bigger picture of the world-wide pharmaceutical market it seems that the situation in every other country is just as unique and different as in my own country. It is interesting to learn how differently the rest of the world approaches the medications side of healthcare. That, in countries such as Veitnam, price and even the availibility of medicines varies from city to city. Drug companies are free to distribute any informative material they wish in Nepal without interference from the government. Issues over things like counterfeit medicines never arise in New Zealand but seem to be a problem in countries like Thailand. The role of community pharmacists in India is very different to the way pharmacy is practiced in New Zealand. I also find it interesting to compare the affordability of drug therapies between other countries and my own.
As a full time student I earn an income working during the weekends, and when making purchases I compare the prices of goods relative to the time I spent working to pay for them. A full tank of petrol costs me six hours of my time at work, and lunch costs me what I earn in thirty minutes. A similar technique was applied in the article titled 'Medicine prices, availability, and affordability in Vietnam' (Vol 2 Issue 2 Sep 2009) where it was reported that an average, unskilled government worker in Veitnam would have to commit twenty one days worth of his wages to cover the cost of one course of innovator brand ranitidine. The lowest price generic brand only costs 1.3 days worth of wages when treatment is sought from the private sector.
Amount of time spent working to pay for medical treatment is an easily understandable unit of measure, far more relevant than the usual method of comparing $ with $, which is usually only reported in US$ and does not take into account affordability, the cost relative to the average wage.
Each article I have read outlines important and challenging issues faced by countries, which are interesting to me because each situation is very different to New Zealand. There are lessons to be learned from the unique solutions which follow, and I look forward to reading future issues while practicing as a pharmacist.
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